GC/MS

Cerno Bioscience GC/MS Software Accelerates Unknown Compound Identification

Retrieved on: 
Wednesday, December 13, 2023
Health, Technology, Health Technology, Other Science, Software, Science, Biotechnology, Cerno, ID, GC, GC/MS, Mass spectrometry, CDS, Workflow, LIMS, Mass, Online shopping

This software release is a significant technological advancement for GC/MS unknown identification and semi-quantification, offering a powerful market-first solution.

Key Points: 
  • This software release is a significant technological advancement for GC/MS unknown identification and semi-quantification, offering a powerful market-first solution.
  • GC/ID is a vendor-neutral software application that accelerates the unknown ID workflow and dramatically improves the confidence of results.
  • This provides for more accurate and confident unknown identification over solutions relying solely on Library Search scores.
  • For more information on GC/ID, please contact Cerno Bioscience at [email protected] , call +1 203-312-1150, or visit www.cernobioscience.com

Assessment of the Chromatography Resin Industry, 2023-2028 Featuring Profiles of Key Players Including Bio-Rad Labs, Merck, Danaher, Tosoh, Sartorius Stedim Biotech - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 29, 2023
Biotechnology, Manufacturing, Health, Pharmaceutical, Chemicals, Plastics, FNB, GC/MS, Drink, Tosoh, Mitsubishi Chemical Corporation, Ligand, Medication, Chromatography, Merck Group, Research, Antibody, USD, Danaher Corporation, Ion exchange, Organization, Nature, Quality control, Growth, A-DNA, Food, World Health Organization, Fine chemical

This comprehensive report meticulously dissects the chromatography resin market, delving into its categorization by type, technique, application, and region, offering size predictions across diverse geographic areas.

Key Points: 
  • This comprehensive report meticulously dissects the chromatography resin market, delving into its categorization by type, technique, application, and region, offering size predictions across diverse geographic areas.
  • Chromatography has emerged as a prominent analytical technique for assessing the quality of processed food products and diverse beverages.
  • This increasing recognition of accurate analytical methods is a key driver behind the growth of the chromatography resin market.
  • Various types of synthetic or manmade polymers, including polyacrylamide, polymethacrylate, and polystyrene, serve as essential media in diverse chromatography applications.

Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals

Retrieved on: 
Monday, July 31, 2023
Software, General Health, Professional Services, Data Management, Sustainability, Technology, Environment, Data Analytics, Clinical Trials, Science, Health, Environmental, Social and Governance (ESG), Other Science, ACT, Workforce, Carbon accounting, GC/MS, PFAS, Life, Historically black colleges and universities, Hydrogen, Cancer, Woman, Delaware State University, Multimedia, TCFD, Black, Targets, Certification, Task force, Student, Task Force on Climate Related Financial Disclosures, GRI, Patient, Chan Eng Heng, Water, Municipal solid waste, STEM, ESG, NYSE, D, Management, Renewable energy, Fine chemical, Agilent Technologies

“That includes helping them achieve their sustainability goals with our products, technology, and services.

Key Points: 
  • “That includes helping them achieve their sustainability goals with our products, technology, and services.
  • Implemented a formal sustainability function in Agilent’s Order Fulfillment division, which embeds sustainability into all aspects of manufacturing, supply chain, and logistics.
  • Agilent’s 2022 report also includes an updated Task Force on Climate-Related Financial Disclosures (TCFD) report, an index of materially relevant topics from the Global Reporting Initiative (GRI), and a SASB index.
  • Read the report and related materials about Agilent’s ESG program at Agilent.com.

Spectrometry Industry Unlocks Growth Potentials in NMR Spectroscopy - Grand View Research, Inc.

Retrieved on: 
Wednesday, June 28, 2023
Food, GC/MS, IR, Ester, NMR, Mass spectrometry, Biotechnology, Biopharma LLC, Biomedical Research, Dicarboxylic acid, Research, Thermo Fisher Scientific, Near-infrared spectroscopy, USD, Proteomics, MS, Athlete, Nuclear magnetic resonance spectroscopy, Paint, Agilent Technologies, Acquisition, GC-MS, Investment, SAN, Drug discovery, Gas chromatography–mass spectrometry, Growth, Virtual Control, PCR, Red Data Book of Ukraine, Software, Fine chemical, Medical imaging

SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.

Key Points: 
  • SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.
  • Forward-looking players have upped investments in molecular spectrometry in pharmaceutical and biotechnology in the wake of innovation in infrared (IR) spectroscopy.
  • Equipment manufacturers have injected funds into mass spectrometry (MS) in the drug development pipeline, applied testing, clinical diagnostics and food products.
  • Order your copy of the Free Sample of "Spectrometry Industry Data Book - Spectrometry, Mass Spectrometry, NMR Spectroscopy, Near-Infrared Spectroscopy and In-line UV-vis Spectroscopy Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research
    An uptick in biomedical research has fueled the penetration of nuclear magnetic resonance (NMR) spectroscopy across business verticals.

Spectrometry Industry Unlocks Growth Potentials in NMR Spectroscopy - Grand View Research, Inc.

Retrieved on: 
Wednesday, June 28, 2023
Food, GC/MS, IR, Ester, NMR, Mass spectrometry, Biotechnology, Biopharma LLC, Biomedical Research, Dicarboxylic acid, Research, Thermo Fisher Scientific, Near-infrared spectroscopy, USD, Proteomics, MS, Athlete, Nuclear magnetic resonance spectroscopy, Paint, Agilent Technologies, Acquisition, GC-MS, Investment, SAN, Drug discovery, Gas chromatography–mass spectrometry, Growth, Virtual Control, PCR, Red Data Book of Ukraine, Software, Fine chemical, Medical imaging

SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.

Key Points: 
  • SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.
  • Forward-looking players have upped investments in molecular spectrometry in pharmaceutical and biotechnology in the wake of innovation in infrared (IR) spectroscopy.
  • Equipment manufacturers have injected funds into mass spectrometry (MS) in the drug development pipeline, applied testing, clinical diagnostics and food products.
  • Order your copy of the Free Sample of "Spectrometry Industry Data Book - Spectrometry, Mass Spectrometry, NMR Spectroscopy, Near-Infrared Spectroscopy and In-line UV-vis Spectroscopy Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research
    An uptick in biomedical research has fueled the penetration of nuclear magnetic resonance (NMR) spectroscopy across business verticals.

Life Science Instrumentation Market worth $73.9 billion | MarketsandMarkets

Retrieved on: 
Friday, May 12, 2023
Allergy, Antigen, Food, GC/MS, Immunogenetics, Health, Genetics, HLA, Transfusion medicine, Allele, NGS, Shimadzu, Personalized medicine, AB, Thermo Fisher Scientific, Element, Danaher Corporation, Science, Patient, Risk, Organ transplantation, Algorithm, Immune system, Cancer, Medicine, Agilent Technologies, Diagnosis, Waters Corporation, Research, LC/MS, Mindful Scientific Inc., Safety, Dentistry, Vaccine, Medical imaging

Life Science Instrumentation Market Advantages:

Key Points: 
  • Life Science Instrumentation Market Advantages:
    Improved Organ Transplantation Success: Accurate Life Science Instrumentation plays a critical role in organ transplantation.
  • Rapid Technological Advancements: The Life Science Instrumentation market benefits from ongoing technological advancements, such as next-generation sequencing (NGS), high-resolution molecular techniques, and advanced data analysis algorithms.
  • Overall, the Life Science Instrumentation market offers significant advantages, including improved organ transplantation outcomes, personalized medicine approaches, enhanced disease diagnosis and treatment, advancements in transfusion medicine, scientific research opportunities, and rapid technological progress.
  • These advantages contribute to the growing importance and widespread utilization of Life Science Instrumentation in the field of healthcare.

Life Science Instrumentation Market worth $73.9 billion | MarketsandMarkets

Retrieved on: 
Friday, May 12, 2023
Allergy, Antigen, Food, GC/MS, Immunogenetics, Health, Genetics, HLA, Transfusion medicine, Allele, NGS, Shimadzu, Personalized medicine, AB, Thermo Fisher Scientific, Element, Danaher Corporation, Science, Patient, Risk, Organ transplantation, Algorithm, Immune system, Cancer, Medicine, Agilent Technologies, Diagnosis, Waters Corporation, Research, LC/MS, Mindful Scientific Inc., Safety, Dentistry, Vaccine, Medical imaging

Life Science Instrumentation Market Advantages:

Key Points: 
  • Life Science Instrumentation Market Advantages:
    Improved Organ Transplantation Success: Accurate Life Science Instrumentation plays a critical role in organ transplantation.
  • Rapid Technological Advancements: The Life Science Instrumentation market benefits from ongoing technological advancements, such as next-generation sequencing (NGS), high-resolution molecular techniques, and advanced data analysis algorithms.
  • Overall, the Life Science Instrumentation market offers significant advantages, including improved organ transplantation outcomes, personalized medicine approaches, enhanced disease diagnosis and treatment, advancements in transfusion medicine, scientific research opportunities, and rapid technological progress.
  • These advantages contribute to the growing importance and widespread utilization of Life Science Instrumentation in the field of healthcare.

Agilent Announced as Instrument Business Outlook 2022 Company of the Year

Retrieved on: 
Monday, March 20, 2023
Technology, Recycling, Professional Services, Environmental, Social and Governance (ESG), Environment, Telecommunications, Sustainability, Software, Networks, Internet, Hardware, Electronic Design Automation, Data Management, Consumer Electronics, ECD, Partnership, GC/MS, Seahorse, Bioinformatics, PSS, Research, Acquisition, Investment, Artificial intelligence, Growth, IBO, Virtual Control, ESG, Helium, Spiral Dynamics, LC/MS, NYSE, Renewable energy, Fine chemical, Agilent Technologies

Agilent Technologies Inc. (NYSE: A) announced today that it has been selected as Instrument Business Outlook (IBO) 2022 Company of the Year.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced today that it has been selected as Instrument Business Outlook (IBO) 2022 Company of the Year.
  • Innovations noted included the HydroInert source, which allows for using of hydrogen instead of helium as the carrier gas in GC/MS.
  • Also, the introductions of new versions of the AssayMAP Bravo Protein Sample Prep Workbench and the Seahorse XF Pro Analyzer.
  • Tanya Samazan, managing editor at IBO noted: “Agilent’s achievements were about annual results as well as years of transforming the company.

Novel Spectrometry Platforms Market, 2022-2035: Need for Automation, Reproducibility and Higher Sensitivity Drives Adoption - ResearchAndMarkets.com

Retrieved on: 
Monday, December 19, 2022
Technology, Other Technology, USD, Miniaturization, Novel, Benchmarking, Mass spectrometry, Biotechnology, Patent, Partnership, Element, CPC, Harvey, GC/MS, SWOT, Quality control, Automation, Food, LC/MS, NMR, XRF, Development director, Type, LECO, Video game, Uranium, 3D printing, Mobile phone, Marketing

The growing popularity of novel spectrometry platforms is also evident from 60+ global events that have been organized in this field, since 2016.

Key Points: 
  • The growing popularity of novel spectrometry platforms is also evident from 60+ global events that have been organized in this field, since 2016.
  • Elaborate profiles of the players offering novel spectrometry platforms (shortlisted on the basis of the year of experience of the company).
  • An analysis of various developments / recent trends related to novel spectrometry, offering insights on partnerships and collaborations and recent initiatives being undertaken related to novel spectrometry platforms.
  • What is the focus area of the ongoing research activities related to novel spectrometry platforms?

American Laboratory Trading & Heritage Global Partners to Host Massive Auction of Lab Equipment from Rubius Therapeutics’ Cambridge Facility

Retrieved on: 
Monday, December 19, 2022
Finance, Data Analytics, Consulting, Professional Services, Asset Management, Laboratory, GC, Food, Aerospace, Metalworking, Asset, Electronics, GC/MS, HGP, ALT, Agilent Technologies, Sale, Real estate, Acquisition, Financial services, Printing, Semiconductor, Plastic, Aviation, Chemical substance

American Laboratory Trading (“ALT”) www.ALT.Bio is a subsidiary of Heritage Global Inc. (NASDAQ: HGBL).

Key Points: 
  • American Laboratory Trading (“ALT”) www.ALT.Bio is a subsidiary of Heritage Global Inc. (NASDAQ: HGBL).
  • ALT is endorsed by 40 states in the BIO Business Solutions program and partners with Agilent which enables buyers to access Agilent factory refurbished analytical instruments including: HPLCs, GC and GC/MS systems.
  • Heritage Global Partners, Inc. ("HGP") www.HGPAuction.com is a subsidiary of Heritage Global Inc. (NASDAQ: HGBL).
  • Heritage Global Inc. (“HG”) www.HGinc.com values and monetizes industrial & financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets.